-
Roche and AscidianTherapeutics Establish an $1.8 Billion RNA Editing Therapy Collaboration
In the tumultuous world of the pharmaceutical industry, the Swiss pharmaceutical giant Roche has once again demonstrated its firm steps in acquisition...
2024-06-24 18:04 -
The Invisible Champion in Children's Medicines - Jichuan Pharmaceutical's Soaring Profits of 2.4 Bil...
Jichuan Pharmaceutical, a pharmaceutical company that has been deeply engaged in the field of children's medicines for many years, has recently announ...
2024-06-24 18:03 -
Oral 28-Day Weight Loss Of 6.8% - Impressive Results From a New Chinese Drug
In recent years, as people's living standards have improved and dietary structures have changed, the problems of overweight and obesity have become in...
2024-06-24 18:02 -
U.S. Biotech Company MustangBio Sees Meteoric 480% Stock Surge on Promising CD20 CAR-T Therapy
MustangBio, a leading U.S. biotech company, has recently achieved a remarkable breakthrough.
2024-06-24 17:55 -
Respiratory Diseases Market Sees New Opportunities
Respiratory diseases, as a major challenge in the field of global public health, have always been the focus of the global medical community and the pu...
2024-06-24 17:54 -
The $40 Billion Pain: Gilead's Bloody Five-Year Journey
Gilead Sciences, a leading global biopharmaceutical company, has actively pursued a series of large-scale merger and acquisition (M&A) strategies over...
2024-06-24 17:53 -
From Acquisition to Failure: Gilead's $4.9 Billion Gamble on CD47-Targeted Therapy
Large pharmaceutical companies often rely on aggressive acquisition strategies to drive innovation and growth.
2024-06-17 15:55 -
The Dilemma and Hope of Huntington's Disease
Huntington's disease, a rare hereditary neurodegenerative disorder, has been through more than 150 years of exploration.
2024-06-17 15:54 -
AbbVie Charges Ahead into New Frontiers with $12.4 Billion Investment
Recently, Ming Jie Bio officially announced that it has formally licensed the global rights of the TL1A antibody FG-M701 to AbbVie.
2024-06-17 15:45 -
A Billion-Dollar Ointment Giant's Growth Story Unveiled
When it comes to Lianrui Pharmaceutical, the public may not be too familiar with the company.
2024-06-17 15:44
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products


